Streetbeat News

Stock Prices

FCX

Freeport-McMoRan (NYSE:FCX) has significantly outperformed the market over the past 5 years, delivering an average annual return of 33.98%. A $1000 investment in FCX 5 years ago would now be worth $4,317.46. The company's current market capitalization is $69.67 billion.

Portfolio Pulse from Benzinga Insights

June 20, 2024 | 6:00 pm

HWM

Howmet Aerospace (NYSE:HWM) has significantly outperformed the market over the past 5 years, delivering an average annual return of 33.55%. A $1000 investment in HWM 5 years ago would now be worth $4,263.94. The company's market capitalization is currently $32.92 billion.

Portfolio Pulse from Benzinga Insights

June 20, 2024 | 6:00 pm

LYRA

Lyra Therapeutics (NASDAQ:LYRA) has received mixed ratings from analysts, with a notable decrease in the average 12-month price target by 43.69%. Analysts have provided a range of price targets from $0.50 to $12.00, reflecting varied expectations. The company's financial metrics show positive revenue growth but challenges in profitability and asset utilization.

Portfolio Pulse from Benzinga Insights

June 20, 2024 | 6:00 pm

RMD

ResMed's short interest has decreased by 3.28%, with 9.87 million shares sold short, representing 7.67% of its float. This is higher than the peer group average of 4.79%. It would take traders 11.87 days to cover their short positions.

Portfolio Pulse from Benzinga Insights

June 20, 2024 | 6:00 pm

FANG

Diamondback Energy (NYSE:FANG) has seen a 3.38% increase in its short percent of float, now at 3.36% of all regular shares available for trading. This indicates a rise in bearish sentiment, although it remains below the peer group average of 7.34%.

Portfolio Pulse from Benzinga Insights

June 20, 2024 | 6:00 pm

TNXP

Tonix Pharmaceuticals shares are trading higher following the receipt of formal minutes from a pre-New Drug Application Type-B Chemistry, Manufacturing, and Controls meeting with the FDA for Tonmya, a treatment for fibromyalgia.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 5:59 pm

FFIE

Faraday Future Intelligence Electric shares are experiencing a decline due to ongoing volatility after a recent surge in retail investor interest.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 5:57 pm

BBLG

Bone Biologics shares are trading lower after the company announced the treatment of the first two patients in a clinical study of its NB1 bone graft device.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 5:54 pm

JNJ

Johnson & Johnson (NYSE:JNJ) is facing a new proposed class action lawsuit related to its talc products, seeking damages and medical monitoring for women who may develop cancer. This follows a recent $700 million settlement for a multi-state investigation into its talc products. The lawsuit, filed in New Jersey federal court, is the first to seek medical monitoring for talc users. The law firms behind the case oppose J&J's $6.48 billion bankruptcy settlement proposal for talc claims. J&J maintains its talc is safe and asbestos-free.

Portfolio Pulse from Vandana Singh

June 20, 2024 | 5:53 pm

AMPX

Amprius Technologies shares are trading higher following the announcement of a strategic initiative to increase global production capacity of its SiCore offering through new manufacturing partnerships.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 5:52 pm